Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hugh

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Circulation|November 7, 2007
Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptorJoanne E Nettleship, T Hugh Jones, Kevin S Channer, et al.
European Journal of Endocrinology|September 4, 2013
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetesVakkat Muraleedharan, Hazel Marsh, Dheeraj Kapoor, et al.
Journal of Public Health Management and Practice : JPHMP|August 26, 2022
COVID-19 Vaccine Uptake in Southeastern Ontario, Canada: Monitoring and Addressing Health InequitiesMegan A Carter, Suzanne Biro, Allison Maier, et al.
International Journal of Clinical Practice|March 21, 2017
UK policy statements on testosterone deficiencyGeoffrey Hackett, Michael Kirby, David Edwards, et al.
European Journal of Endocrinology|August 14, 2023
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trialT Hugh Jones, Adrian S Dobs, Harpal Randeva, et al.
European Journal of Endocrinology|June 23, 2009
Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in menAtish Mathur, Christopher Malkin, Basil Saeed, et al.
Endocrine Research|December 20, 2002
Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factorsPeter J Pugh, Kevin S Channer, Helen Parry, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|October 15, 2024
Isolation to stabilization: A Housing First approach to address homelessness in Kingston, OntarioYvonne Tan, Zack Revell, Victoria Wilson, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|December 31, 2024
Embracing Housing First as a continuum: A response to "Safeguarding against the degradation of Housing First"Sahar Saeed, Yvonne Tan, Zack Revell, et al.
Biochemical and Biophysical Research Communications|May 4, 2004
Testosterone is a potent inhibitor of L-type Ca(2+) channelsJason L Scragg, Richard D Jones, Kevin S Channer, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Circulation|November 7, 2007
Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptorJoanne E Nettleship, T Hugh Jones, Kevin S Channer, et al.
European Journal of Endocrinology|September 4, 2013
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetesVakkat Muraleedharan, Hazel Marsh, Dheeraj Kapoor, et al.
Journal of Public Health Management and Practice : JPHMP|August 26, 2022
COVID-19 Vaccine Uptake in Southeastern Ontario, Canada: Monitoring and Addressing Health InequitiesMegan A Carter, Suzanne Biro, Allison Maier, et al.
International Journal of Clinical Practice|March 21, 2017
UK policy statements on testosterone deficiencyGeoffrey Hackett, Michael Kirby, David Edwards, et al.
European Journal of Endocrinology|August 14, 2023
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trialT Hugh Jones, Adrian S Dobs, Harpal Randeva, et al.
European Journal of Endocrinology|June 23, 2009
Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in menAtish Mathur, Christopher Malkin, Basil Saeed, et al.
Endocrine Research|December 20, 2002
Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factorsPeter J Pugh, Kevin S Channer, Helen Parry, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|October 15, 2024
Isolation to stabilization: A Housing First approach to address homelessness in Kingston, OntarioYvonne Tan, Zack Revell, Victoria Wilson, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|December 31, 2024
Embracing Housing First as a continuum: A response to "Safeguarding against the degradation of Housing First"Sahar Saeed, Yvonne Tan, Zack Revell, et al.
Biochemical and Biophysical Research Communications|May 4, 2004
Testosterone is a potent inhibitor of L-type Ca(2+) channelsJason L Scragg, Richard D Jones, Kevin S Channer, et al.
Pageof 10